Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

Insmed (INSM) Stock Price Prediction and News Highlight
Thu. Nov 20, 2025

The biopharmaceutical industry is witnessing significant innovation, as evidenced by the introduction of BRINSUPRI as a first-in-class treatment. Insmed's commitment to product development is further underscored by the promising results from its phase III ASPEN and phase II WILLOW trials, showcasing effective advancements in therapies for lung diseases. These efforts not only highlight the company's position in developing targeted therapies but also reflect an overall positive trend in addressing serious health conditions. However, challenges remain in navigating regulatory approvals and market competition.

The price action of Insmed (INSM) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 1 is bullish. The market sentiment at 1.3 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.INSM is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.3, and the negative at 0 on 2025-11-20. The forces of Sentiment towards Fundamentals (3), Valuation Sentiment (2.4), Market Risk Appetite (1), Sector Price Trend (1), Stock Price Trend (1), Option Sentiment (0), and Price Level Sentiment (0) will drive up the price. The forces of and Price Level Sentiment (0) will drive down the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-02-18 10:00, EPS: $-6.19, P/E: -32.25

INSM
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-11-200%(0%)    1    0.25%    1.3          3    -1   
2025-11-190%(0%)    1    0.25%    1          3.4    -1   
2025-11-180%(0%)    1    0.25%    1.2          2.9    -1   
2025-11-170%(0%)    1    0.25%    1.3          2.2    -1   
2025-11-160%(0%)    1    0.25%    1.2          2.2    -1   
2025-11-150%(0%)    1    0.25%    1.2          2.6    -1   
2025-11-140%(0%)    1    0.25%    1.2          2.6    -1   
2025-11-130%(0%)    1    0.25%    1.2          2.9    -1   
2025-11-120%(0%)    1    0.25%    1          1    -1   
2025-11-110%(0%)    1    0.25%    0.8          1.9    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-11-20 17:09:43 The article highlights a strategy of diversifying investments within the stock market, particularly in biopharmaceuticals.
2025-11-20 17:09:43 The financial activities of Catalyst indicate expected performance metrics of Insmed which could influence earnings outlook.
2025-11-20 17:09:43 The purchase reflects a trend where investment funds are showing interest in the biopharmaceutical industry.
2025-11-20 17:09:43 The purchasing of shares reflects a belief in the potential for Insmed's growth, suggesting optimism about its stock valuation.
2025-11-20 17:09:43 The article discusses Catalyst Funds Management's investment in Insmed, indicating positive interest in the biopharmaceutical sector.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA